Predictor's of quality of life in ulcerative colitis: The importance of symptoms and illness representations

Inflammatory Bowel Diseases

Volumn 11, Issue 1, 2005, Pages 24-34

  Han, Seong Won ^a   McColl, Elaine ^b   Barton, John Roger ^a   James, Peter ^a   Steen, Ian Nicholas ^b   Welfare, Mark Richard ^a  

^a NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Illness representation; Inflammatory bowel disease; Symptoms; Ulcerative colitis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORRELATION FUNCTION; DEMOGRAPHY; DISEASE ACTIVITY; ENTERITIS; FEMALE; GENDER; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL HEALTH; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; SCORING SYSTEM; SELF REPORT; STATISTICAL ANALYSIS; STATISTICAL MODEL; SYMPTOMATOLOGY; ULCERATIVE COLITIS; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; SELF CONCEPT; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 13944271403     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200501000-00004     Document Type: Article

References (59)

1. Stonnington CM, Phillips SF, Zinsmeister AR, et al. Prognosis of chronic ulcerative colitis in a community. Gut. 1987;28:1261-1266.
2. Hendriksen C, Binder V. Social prognosis in patients with ulcerative colitis. BMJ. 1980;281:581-583.
3. Fitzpatrick R, Davey C, Buxton MJ, et al. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess. 1998; 2:1-74.
4. Kim WH, Cho YS, Yoo HM, et al. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Colorectal Dis. 1999;14:52-57.
5. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96: 804-810.
6. Irvine EJ. Quality of life: rationale and methods for developing a disease-specific instrument for inflammatory bowel disease. Scand J Gastroenterol. 1993;28:22-27.
7. Irvine EJ. Quality of life: measurement in inflammatory bowel disease. Scand J Gastroenterol. 1993;28:36-39.
8. Maunder R, Toner B, de Rooy E, et al. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol. 1999;13:728-732.
9. Irvine EJ. Quality of Life in inflammatory bowel disease: biases and other factors affecting scores. Scand J Gastroenterol Suppl 1995;208:136-140.
10. Casellas F, Lopez-Vivancos J, Casado A, et al. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002;11:775-781.
11. Robinson M, Hanauer S, Hoop R, et al. Mesalamine capsules enhance the quality of life for patients with ulcerative colitis. Aliment Pharmacol Ther. 1994;8:27-34.
12. Green JR, Lobo AJ, Holdsworth CD, et al. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis: the Abacus Investigator Group. Gastroenterology 1998;114: 15-22.
13. Thirlby RC, Land JC, Fenster LF, et al. Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg. 1998;133:826-832.
14. Thirlby RC, Sobrino MA, Randall JB. The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg. 2001;136:521-527.
15. Farmer RG, Easley KA, Farmer JM. Quality of life assessment by patients with inflammatory bowel disease. Cleve Clin J Med. 1992;59:35-42.
16. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am J Gastroenterol. 1995;90:1450-1454.
17. Walker EA, Gelfand MD, Gelfand AN, et al. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry. 1996;18:220-229.
18. Verissimo R, Mota-Cardoso R, Taylor G. Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease. Psychother Psychosom. 1998;67:75-80.
19. Cuntz U, Welt J, Ruppert E, et al. Determination of subjective burden from chronic inflammatory bowel disease and its psychosocial consequences: results from a study of 200 patients. Psychother Psychosom Med Psychol. 1999;49:494-500.
20. Moskovitz DN, Maunder RG, Cohen Z, et al. Coping behavior and social support contribute independently to quality of life after surgery for inflammatory bowel disease. Dis Colon Rectum. 2000;43:517-521.
21. Smolen DM, Topp R. Coping with methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being. Gastroenterol Nurs. 1998;21:112-118.
22. MacPhee M, Hoffenberg EJ, Feranchak A. Quality-of-life factors in adolescent inflammatory bowel disease. Inflamm Bowel Dis 1998;4:6-11.
23. Colombel JF, Yazdanpanah Y, Laurent F, et al. Quality of life in chronic inflammatory bowel diseases: validation of a questionnaire and first French data. Gastroenterol Clin Biol. 1996;20:1071-1077.
24. Hjortswang H, Strom M, Almeida RT, et al. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32:1235-1240.
25. Leventhal H, Nerenz DR, Steele DJ. Illness representations and coping with health threats. In: Baum A, Taylor SE, Singer JE, eds. Handbook of Pyschology and Health: Volume IV: Social and Psychological Aspects of Health. New York: Wiley; 1984:219-252.
26. Leventhal H, Diefenbach M. The active side of illness cognition. In: Skelton JA, Croyle RT, eds. Mental Representation in Health and Illness. New York: Springer-Verlag; 1991:247-272.
27. Leventhal H, Leventhal EA, Contrada RJ. Self-regulation, health and behaviour: a perceptual-cognitive approach. Psychol Health 1998;13:717-733.
28. Hampson SE, Glasgow RE, Zeiss AM. Personal models of osteoarthritis and their relation to self-management activities and quality of life. J Behav Med. 1994;17:143-158.
29. Hampson SE, Glasgow RE, Foster LS. Personal models of diabetes among older adults: relationship to self-management and other variables. Diabetes Educ. 1995;21:300-307.
30. Scharloo M, Kaptein AA. Measurement of illness perception in patients with chronic somatic illness: a review. In: Petrie KJ, Weinman JA, eds. Perceptions of Health and Illness. Amsterdam: Harwood Academic Publishers; 1997:103-154.
31. Scharloo M, Kaptein AA, Weinman J, et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res. 1998;44:573-585.
32. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330: 1841-1845.
33. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease: Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287-296.
34. de Boer AGEM, Wijker W, Bartelsman JFW, et al. Inflammatory bowel disease questionnaire: cross-cultural adaptation and further validation. Eur J Gastroenterol Hepatol. 1995;7:1043-1050.
35. Russel MG, Pastoor CJ, Brandon S, et al. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997;58:282-288.
36. Lopez-Vivancos J, Casellas F, Badia X, et al. Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion. 1999; 60:274-280.
37. Cheung WY, Garratt AM, Russell IT, et al. The UK IBDQ - a British version of the inflammatory bowel disease questionnaire, development and validation. J Clin Epidemiol. 2000;53:297-306.
38. Han SW, McColl E, Steen N, et al. The Inflammatory Bowel Disease Questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England. Scand J Gastroenterol. 1998;33:961-966.
39. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
40. Ware JE Jr, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264-AS279.
41. Weinman J, Petrie KJ, Moss-Morris R, et al. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health. 1996;11:431-445.
42. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36):II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31: 247-263.
43. Glasgow RE, Ruggiero L, Eakin EG, et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20:562-567.
44. Rebollo P, Ortega F, Baltar JM, et al. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant. 2000;14:199-207.
45. Sprangers MA, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000; 53:895-907.
46. Kaplan GA, Camacho T. Perceived health and mortality: a nine-year follow-up of the human population laboratory cohort. Am J Epidemiol. 1983; 117:292-304.
47. Gijsbers van Wijk CM, Kolk AM. Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med 1997;45: 231-246.
48. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994;17:267-274.
49. Lichtenstein GR, Yan S, Bala M, et al. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol. 2004;99:91-96.
50. Fullwood A, Drossman DA. The relationship of psychiatric illness with gastrointestinal disease. Annu Rev Med. 1995;46:483-496.
51. Talal AH, Drossman DA. Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin North Am. 1995;24:699-716.
52. Duffy LC, Zielezny MA, Marshall JR, et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med. 1991;17:101-110.
53. Addolorato G, Stefanini GF, Capristo E, et al. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness? Hepatogastroenterology. 1996;43:1513-1517.
54. Greene BR, Blanchard EB, Wan CK. Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther. 1994;32:217-226.
55. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994;89:1219-1225.
56. Porcelli P, Leoci C, Guerra V, et al. A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychosom Res. 1996;41:569-573.
57. Carter MJ, Lobo AJ, Travis SPL. on behalf of the IBD section of the British Society of Gastroenterology: guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53:v1-v16.
58. Robinson A, Thompson DG, Wilkin D, et al. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial; Northwest Gastrointestinal Research Group. Lancet 2001;358:976-981.
59. Green JRB, Swan CHJ, Gibson JA, et al. Patient-led variable doing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study. Aliment Pharmacol Ther. 2004; 19:435-442.